evidence card · nmn_raises_nad_humans
NMN supplementation raises NAD+ levels in humans
H4
▲ supports
stakes moderate
2 posts scored
·
across 2 accounts
·
2 sources
Summary
Multiple small human RCTs show NAD+ metabolite elevation. The biomarker moves; whether it matters clinically is the weaker claim below.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
generally healthy adults, often middle-aged+
Intervention
oral NMN, typically 250-900 mg/d for weeks-months
Outcome
whole-blood or tissue NAD+ / NAD metabolites
Not supported for
- specific health outcomes from NAD+ elevation